Skip to content

Clinical trials

Phase 3 Heart Failure trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 3 Country / region: South Korea Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20131
20143
20161
20173
20182
20192
20201
20231
20243
20254
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting10
Terminated4
Active, not recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim4
Novartis Pharmaceuticals4
AstraZeneca3
Bayer3
Lexicon Pharmaceuticals2
Novo Nordisk A/S2
Amgen1
Boston Scientific Corporation1
CSL Behring1
Colorado Prevention Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure29
Coronary Artery Disease3
Diabetes Mellitus, Type 23
Myocardial Infarction2
Obesity2
Stroke2
Ventricular Dysfunction, Left2
Acute Coronary Syndrome1
Atherosclerosis1
Atrial Fibrillation1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.